These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34164881)

  • 21. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A collective European experience with left atrial appendage suture ligation using the LARIAT+ device.
    Tilz RR; Fink T; Bartus K; Wong T; Vogler J; Nentwich K; Panniker S; Fang Q; Piorkowski C; Liosis S; Gaspar T; Sawan N; Metzner A; Nietlispach F; Maisano F; Lee RJ; Foran JP; Ouyang F; Sievert H; Deneke T; Kuck KH
    Europace; 2020 Jun; 22(6):924-931. PubMed ID: 32044994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
    Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
    Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
    López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.
    Ailawadi G; Gerdisch MW; Harvey RL; Hooker RL; Damiano RJ; Salamon T; Mack MJ
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1002-9, 1009.e1. PubMed ID: 21906756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epicardial left atrial appendage AtriClip occlusion reduces the incidence of stroke in patients with atrial fibrillation undergoing cardiac surgery.
    Caliskan E; Sahin A; Yilmaz M; Seifert B; Hinzpeter R; Alkadhi H; Cox JL; Holubec T; Reser D; Falk V; Grünenfelder J; Genoni M; Maisano F; Salzberg SP; Emmert MY
    Europace; 2018 Jul; 20(7):e105-e114. PubMed ID: 29016813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early safety of the Amplatzer Cardiac Plug™ for left atrial appendage occlusion.
    Meerkin D; Butnaru A; Dratva D; Bertrand OF; Tzivoni D
    Int J Cardiol; 2013 Oct; 168(4):3920-5. PubMed ID: 23890886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of left atrial appendage closure in non-valvular atrial fibrillation in patients over 75 years.
    Yu J; Chen H; Post F; Muenzel M; Keil T; Hou CR; Zhao M; Meng Z; Jiang L
    Heart Vessels; 2019 Nov; 34(11):1858-1865. PubMed ID: 31144099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epicardial left atrial appendage occlusion with a new medical device: assessment of procedural feasibility, safety and efficacy in a large animal model.
    Emmert MY; Firstenberg MS; Martella AT; Lau L; Zlock S; Mohan A; Spangler T; Currie S; Salzberg SP; Caliskan E
    J Cardiothorac Surg; 2020 Apr; 15(1):56. PubMed ID: 32245388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left atrial appendage closure device implantation in patients at very high risk for stroke.
    Hutt E; Wazni OM; Kaur S; Saliba WI; Tarakji KG; Kapadia S; Aguilera J; Barakat AF; Abdallah M; Jaber W; Rasmussen P; Hussain S; Uchino K; Wisco D; Lindsay BD; Kanj M; Hussein AA
    Heart Rhythm; 2020 Jan; 17(1):27-32. PubMed ID: 31302250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformal Left Atrial Appendage Seal Device for Left Atrial Appendage Closure: First Clinical Use.
    Sommer RJ; Kim JH; Szerlip M; Chandhok S; Sugeng L; Cain C; Kaplan AV; Gray WA
    JACC Cardiovasc Interv; 2021 Nov; 14(21):2368-2374. PubMed ID: 34736735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application.
    Pillai AM; Kanmanthareddy A; Earnest M; Reddy M; Ferrell R; Nath J; Pillarisetti J; Vallakati A; Lakkireddy D
    Heart Rhythm; 2014 Nov; 11(11):1877-83. PubMed ID: 24993460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Periprocedural Colchicine on Postprocedural Management in Patients Undergoing a Left Atrial Appendage Ligation Using LARIAT.
    Gunda S; Reddy M; Nath J; Nagaraj H; Atoui M; Rasekh A; Ellis CR; Badhwar N; Lee RJ; DI Biase L; Mansour M; Ruskin JN; Natale A; Earnest M; Lakkireddy DR
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):60-4. PubMed ID: 26515657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
    Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.
    Asmarats L; Masson JB; Pagnotta PA; Cook S; Foresti M; Ibrahim R; Sukiennik A; Sabiniewicz R; Maffeo D; Carballo J; Cruz-González I; Grasso C; Pisano F; Senatore G; Tarantini G; Kasongo A; Chiarito M; Puricel S; Messas N; Moreno-Samos JC; O'Hara G; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Oct; 11(19):1932-1941. PubMed ID: 30249439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry.
    Kefer J; Vermeersch P; Budts W; Depotter T; Aminian A; Benit E; Stammen F
    Acta Cardiol; 2013 Dec; 68(6):551-8. PubMed ID: 24579432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.